關鍵數據
0.519今開
0.519最高
364.90K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.89%換手率
0.517昨收
0.493最低
133.58K成交額
虧損本益比靜
32.43市淨率
0.00%股息率 TTM
-310.39%ROA
4.00052週最高
1.33量比
-19.45M淨利潤
41.13M總股本
-0.5587每股盈餘TTM
-0.86Beta
-495.61%ROE
0.54052週最低
5.10%振幅
--毛利率
20.59M總市值
-3.86回報/風險
7.30%風險率
Heartbeam Inc新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
29
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Heartbeam Inc簡介
HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
公司代碼BEAT
公司Heartbeam Inc
CEOEno (Robert P)
網址https://www.heartbeam.com/
公司股東
常見問題
Heartbeam Inc(BEAT)的當前股價是多少?
Heartbeam Inc(BEAT)的當前股價是 0.50。
Heartbeam Inc股票的52週最高點是多少?
Heartbeam Inc股票的52週最高點是4.00。
Heartbeam Inc股票的52週最低點是多少?
Heartbeam Inc股票的52週最低點是0.54。
現在Heartbeam Inc(BEAT)的股票是買入、持有還是賣出?
根據分析師評級,Heartbeam Inc(BEAT)的總體評級為買入,目標價格為3.38。
Heartbeam Inc(BEAT)股票的每股收益(EPS TTM)是多少
Heartbeam Inc(BEAT)股票的每股收益(EPS TTM)是-0.62。